lURIE CANCER CENTER AND Northwestern Medicine
EXPERTS TO PRESENT AT THE 2024 ASCO® Annual Meeting
Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present and discuss leading-edge research in cancer care at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 - June 4 at McCormick Place in Chicago, and Online. Visit us at Booth 13013.
The program features more than 200 sessions complementing the meeting’s theme: The Art and Science of Cancer Care: From Comfort to Cure. Below is a sample of presentations by Lurie Cancer Center and Northwestern Medicine physicians and scientists.
The program features more than 200 sessions complementing the meeting’s theme: The Art and Science of Cancer Care: From Comfort to Cure. Below is a sample of presentations by Lurie Cancer Center and Northwestern Medicine physicians and scientists.
a sample of our presentation schedule
|
Date
|
Time
|
Location
|
Track & Session
|
Presenter
|
Learn More
|
|
Friday, May 31
|
1:00 – 2:15 PM
|
E450b / On Demand
|
Hematologic Malignancies
Education Session: Germline Predisposition in Hematologic Malignancies / Testing, Management and Implications |
Lucy Godley, MD, PhD Overcoming Barriers to Testing and Research in Patients with Myeloid Predisposition States
|
|
|
|
2:45 – 5:45 PM
|
Hall D1 / Live Stream
|
Melanoma / Skin Cancers
Oral Abstract Session |
Sunandana Chandra, MD Everything and the Kitchen Sink: First-Line Therapy for Advanced Melanoma
|
|
|
|
4:30 - 5:45 PM
|
E450a / On Demand
|
Genitourinary Cancer—Prostate, Testicular, and Penile | Disparities/Health Equity
Advancing Prostate Cancer Care: Treatment Approaches to Precision Medicine, Biomarker Innovations, and Equitable Access |
David VanderWeele, MD, PhD
Practical Approach to Genetic Testing and Treatment Selection in Prostate Cancer |
|
Saturday, June 1
|
9:00 AM – 12:00 PM
|
Hall A / On Demand
|
Care Delivery and Quality Care / Digital Technology
Poster Session |
Betina Yanez, PhD
Association of symptom severity, anxiety, and health literacy with portal usage among patients with cancer |
|
|
|
9:00 AM – 12:00 PM
|
Hall A / On Demand
|
Central Nervous System Tumors / Brain Metastases
Poster Session |
Priya Kumthekar, MD
Novel non-invasive method for measuring intracranial pressure for drug delivery and other neurologic disorders Abstract: 2031 |
|
|
Sunday, June 2
|
9:00 AM – 12:00 PM
|
Hall A / On Demand
|
Genitourinary Cancer – Kidney and Bladder
Urothelial Cancer – Advanced/Metastatic Disease |
Maha Hussain, MD, FASCO, FACP
A pilot study of tazemetostat and pembrolizumab in advanced urothelial carcinoma (ETCTN 10183). |
|
|
|
9:00 AM – 12:00 PM
|
Hall A / On Deman
|
Genitourinary Cancer – Prostate Cancer, Advanced/Hormone Sensitive
Genitourinary Cancer – Prostate, Testicular and Penile |
Sarah Elizabeth Fenton, MD, PhD A randomized phase II study of ADT + abiraterone versus ADT + abiraterone + docetaxel in patients with low-volume metastatic hormone-sensitive prostate cancer.
Abstract: TPS5121 |
|
|
Monday, June 3
|
8:00 – 9:15 AM
|
Hall D2
|
Breast Cancer
Education Session: Systemic Therapy in Breast Cancer: Current State of the Art and Future Horizons |
William Gradishar, MD. FACP, FASCO Tailoring Treatment to Risk: Adjuvant Therapy for Breast Cancer
|
|
connect with us on social
Use #ASCO24 to follow and share insights from the meeting on Twitter, tagging:
- Lurie Cancer Center: @LurieCancer
- Northwestern Medicine: @NorthwesternMed
NORTHWESTERN MEDICINE onCOLOGY
|
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital is a global leader in the treatment of a broad range of cancer types due to its dedication to comprehensive clinical oncology research, world-renowned faculty, physicians and oncologists, and its commitment to making breakthroughs in medical, surgical, radiation and interventional oncology. The Lurie Cancer Center is designated by the National Cancer Institute as one of only 57 comprehensive cancer centers in the nation recognized for their scientific leadership, resources and the depth and breadth of their research. In addition, Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network (NCCN) and our physicians actively participate in writing NCCN patient guidelines for each type cancer.
|